Exagen (XGN) Net Equity Issued and Repurchased (2021 - 2025)

Exagen's (XGN) quarterly Net Equity Issued and Repurchased came in at -$38000.0 in Q4 2025, down 101.12% on a QoQ basis from $3.4 million in Q3 2025.

Exagen (XGN) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends

Exagen (XGN) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$38000.0 in Q4 2025.

Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$38000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.4 million (changed N/A YoY) and the FY2025 annual result came in at $3.4 million, changed N/A from the prior year.
Net Equity Issued and Repurchased declined to -$38000.0 in Q4 2025, from $3.4 million in the prior quarter.
In the past five years, Net Equity Issued and Repurchased ranged from a high of $69.1 million in Q1 2021 to a low of -$38000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn	-
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn	-
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn	-
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn	-
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn	-
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn	-
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn	-
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn	-
10	Exagen	154.89 Mn	130.29 Mn	12.22 Mn	-

Download Data